StockData
REGENXBIO Inc. logo

REGENXBIO Inc. (RGNX) stock

RGNXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$7.26+0.02 (+0.28%)

Close on Nov 18, 2026Market cap $479.26MP/E –Yield –

Regenxbio pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Regenxbio's pe ratio was 13.6× on Jan 31, 2023, against 18.5× a year earlier. Over the last 2 years it ranged from 8.8× to 51.6×, with a median of 18.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 202313.6×+0.3
2022Dec 30, 202213.3×−5.1
2019Apr 30, 201918.5×−0.0
2018Dec 31, 201818.5×–

More Regenxbio figures

See a number that looks wrong?